Shionogi & Co., Ltd. (Headquartered in Osaka, Japan; CEO: Isao Teshirogi, Ph.D.; hereafter referred to as “Shionogi”) has announced revisions to its dividend forecasts for the fiscal year ending March 31, 2024 (fiscal 2023; April 1, 2023 – March 31,…
BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a prominent global oncology firm, has unveiled its 2023 Responsible Business & Sustainability Report, spotlighting the company’s strategic direction, progress towards existing objectives, and its vision for achieving ambitious new targets. This…
Bayer Group’s divisions demonstrated resilience and strength in several core areas, surpassing industry peers, according to CEO Bill Anderson during the virtual Annual Stockholders’ Meeting. Anderson praised the progress in cancer and Parkinson’s disease drug research, herbicide development, and bolstering…
Biogen Inc. (Nasdaq: BIIB) has announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has given a favorable opinion for TOFIDENCE™ (tocilizumab), a biosimilar monoclonal antibody referencing ROACTEMRA®1. The intravenous formulation…
Bio-Techne Corporation (NASDAQ: TECH), a renowned global life sciences company specializing in innovative tools and bioactive reagents for both research and clinical diagnostics, has officially initiated legal proceedings in the Unified Patent Court of Europe. The aim is to address…
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and TreeFrog Therapeutics have announced an exclusive licensing agreement, granting Vertex access to TreeFrog’s cutting-edge cell manufacturing technology, C-Stem™. This collaboration aims to optimize the production of Vertex’s cell therapies tailored for treating type 1…
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and TreeFrog Therapeutics have announced an exclusive licensing agreement, granting Vertex access to TreeFrog’s cutting-edge cell manufacturing technology, C-Stem™. This collaboration aims to optimize the production of Vertex’s cell therapies tailored for treating type 1…
Roche Reports 2% Growth in Group Sales Despite Currency Impact In the first quarter of 2024, Roche saw a 2% increase in group sales at constant exchange rates (CER), though a 6% decrease was observed in Swiss francs (CHF) due…
Allergan Aesthetics, a division of AbbVie (NYSE: ABBV), is extending an invitation to consumers to participate in future campaigns featuring their flagship brands, such as BOTOX® Cosmetic, the JUVÉDERM® Collection of Fillers, and Allē, their loyalty rewards program. Starting today,…
When a patient chooses a medication crafted by Orion, they can trust they’re receiving precisely the indicated dosage of active ingredients,” highlights Tomi Pitkäniemi, Automation Manager, underlining the critical role of his team’s efforts. Pitkäniemi heads the Design and Development…
In April, we annually commemorate Earth Day, underscoring the collaborative endeavor required to forge a healthier environment for the forthcoming generations. This year’s Earth Day theme, “Planet versus Plastics,” spotlights the pervasive issue of plastic pollution, emphasizing the staggering reality…
Bristol Myers Squibb (NYSE: BMY) and Cellares, the pioneering Integrated Development and Manufacturing Organization (IDMO) dedicated to cell therapy manufacturing, have announced a significant worldwide capacity reservation and supply agreement. Valued at up to $380M in upfront and milestone payments,…